[68Ga]Ga-XT771

N/A

Report date: 2025/11/28 15:16:50

NME

Base Information

Drug Name[68Ga]Ga-XT771

Drug Alias Name[68Ga]Ga-XT771

ClassificationRadiation-emitting products > Radioactive diagnostic agentSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Gallium > 68Ga +[5]

Mechanisms of ActionPositron-emission tomography enhancers

TargetsUpdating

Therapy Area/IndicationsCarcinoma, Renal CellGlioblastoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesPla General Hospital

China Registration ClassN/A

Develop Information

Active CompaniesPla General Hospital

Inactive CompaniesN/A

Active IndicationsCarcinoma, Renal CellGlioblastoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A